Ovarian cancer biomarkers for molecular biosensors and translational medicine. - Wikidata - wikimedia - TriplyDB

Ovarian cancer biomarkers for molecular biosensors and translational medicine.

Ovarian cancer biomarkers for molecular biosensors and translational medicine.

http://www.wikidata.org/entity/Q34150097

about

Cancer cell-specific oligopeptides selected by an integrated microfluidic system from a phage display library for ovarian cancer diagnosis.From comorbidities of chronic obstructive pulmonary disease to identification of shared molecular mechanisms by data integration.Towards an animal model of ovarian cancer: cataloging chicken blood proteins using combinatorial peptide ligand libraries coupled with shotgun proteomic analysis for translational research Assessment of circulating copy number variant detection for cancer screening.Threonyl-tRNA synthetase overexpression correlates with angiogenic markers and progression of human ovarian cancer Cancer association study of aminoacyl-tRNA synthetase signaling network in glioblastoma Development of multiplexed bead-based immunoassays for the detection of early stage ovarian cancer using a combination of serum biomarkers Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes.Plasma miRNAs as diagnostic and prognostic biomarkers for ovarian cancer.Detection of amyloid-β42 using a waveguide-coupled bimetallic surface plasmon resonance sensor chip in the intensity measurement mode.The serine protease prostasin (PRSS8) is a potential biomarker for early detection of ovarian cancer.N-glycan MALDI Imaging Mass Spectrometry on Formalin-Fixed Paraffin-Embedded Tissue Enables the Delineation of Ovarian Cancer Tissues.Clinical Significance of Tissue Factor Pathway Inhibitor 2, a Serum Biomarker Candidate for Ovarian Clear Cell Carcinoma.Vascular endothelial growth factor expression correlates with serum CA125 and represents a useful tool in prediction of refractoriness to platinum-based chemotherapy and ascites formation in epithelial ovarian cancer.Early detection biomarkers for ovarian cancer.Ovarian cancer: in search of better marker systems based on DNA repair defects Translational researches require effective protocols for knowledge and technology transfer and integration.Ascites analysis by a microfluidic chip allows tumor-cell profiling.Identification of expressed and conserved human noncoding RNAs.Investigation on tissue specific effects of pro-apoptotic micro RNAs revealed miR-147b as a potential biomarker in ovarian cancer prognosis.Ovarian cancer: risk factors, treatment and management.The current status of heart failure diagnostic biomarkers.Random Assay in Radioimmunoassay: Feasibility and Application Compared with Batch Assay.Real-time impedance analysis of silica nanowire toxicity on epithelial breast cancer cells.The role of HE4 in ovarian cancer: inhibiting tumour cell proliferation and metastasis.Detection of OPCML methylation, a possible epigenetic marker, from free serum circulating DNA to improve the diagnosis of early-stage ovarian epithelial cancer.No advantages of laparoscopy for left-sided malignant colonic obstruction compared with open colorectal resection in both short-term and long-term outcomes.Vascular endothelial growth factor (VEGF) improves the sensitivity of CA125 for differentiation of epithelial ovarian cancers from ovarian cysts.Vibrational biospectroscopy coupled with multivariate analysis extracts potentially diagnostic features in blood plasma/serum of ovarian cancer patients.Thioredoxin 1 as a serum marker for ovarian cancer and its use in combination with CA125 for improving the sensitivity of ovarian cancer diagnoses.

P2860

Q30418500-CE37AD42-FAA8-4B8F-AD6A-5E51BD5744CE Q31160925-16777E60-FBE4-4E06-ADC6-AADA61C23716 Q33576391-EE362C39-EB86-43AD-AF86-B5729CFA3021 Q33884196-3429C72B-66A9-44DA-9B03-771CB0AAEAE7 Q34135915-2A10AE85-E61A-403B-9543-2C1B5B734B4D Q34404633-57C3ED87-324F-4B2C-A729-FFBECCDF697C Q34412873-8AC16FBF-FBE6-4886-A106-2C289F12E14B Q34738849-6B510A40-FB83-4702-A381-74A0B1580095 Q35040690-C43819EE-6564-43A1-99AE-B4B6CDC99E0D Q35183940-446ABF84-FDA1-4A8C-A02C-1FCFA162B508 Q35976828-DC0B66BA-CE3B-4214-9591-61F01F42C4F6 Q36076879-CB90BDB8-797A-49F7-B6B3-2B21E56DD22D Q36178605-40D6F3A6-F3E0-4F64-916D-36F364B34193 Q36414088-A9BBE526-1F45-458E-BA47-2BAB6254563D Q36520143-3108FBF4-DA12-44E5-9442-17DC649FE030 Q36589947-6B54D1FE-F678-45B9-8ABC-B88D59743319 Q36829315-2F873D95-7FD3-412C-8E48-8318D88D7712 Q37409535-71E921B1-2674-4327-8CC8-F16823111750 Q37491729-F131A37B-34D1-4C6A-A081-AE3D8A846A8B Q37745830-117EB29A-EEC4-42D7-A2F0-555A7430B5FC Q38143316-331B75BD-6DC3-4C6B-A6B0-23033D74116E Q38703882-19156ED0-B99C-41E3-B55F-42730981D749 Q39043982-F4985C6A-69C8-489E-BA02-C85B33042F2F Q39250481-73EE09AE-6DB5-4264-BE32-89412BA1E7EF Q39437253-01A59659-66C0-47A9-9818-706025D73D00 Q40978479-BA9598FA-B7F8-436E-8A7C-DA47390795F9 Q44167058-8AAC1964-44C3-43E5-B2E4-523642CDE1AD Q45152682-737F297B-5F04-4819-AA9E-B1249AB89C80 Q51139743-D8196199-D63F-426F-957D-116CDBDC3323 Q53262363-0B6A885B-4284-460F-9224-28160FFB5470

P2860

Ovarian cancer biomarkers for molecular biosensors and translational medicine.

http://www.wikidata.org/entity/Q34150097

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Ovarian cancer biomarkers for molecular biosensors and translational medicine.

@ast

Ovarian cancer biomarkers for molecular biosensors and translational medicine.

@en

Ovarian cancer biomarkers for molecular biosensors and translational medicine.

@nl

type

label

Ovarian cancer biomarkers for molecular biosensors and translational medicine.

@ast

Ovarian cancer biomarkers for molecular biosensors and translational medicine.

@en

Ovarian cancer biomarkers for molecular biosensors and translational medicine.

@nl

prefLabel

Ovarian cancer biomarkers for molecular biosensors and translational medicine.

@ast

Ovarian cancer biomarkers for molecular biosensors and translational medicine.

@en

Ovarian cancer biomarkers for molecular biosensors and translational medicine.

@nl

P1433

Q34150097-7A3DF5C1-7078-40B8-9B0E-944CCD9A5286

P1476

Q34150097-A74FFCF5-33A0-4141-88EA-A76E7A098CC2

P2093

Q34150097-7FAFDB75-77BB-4CD0-9A60-3250C2A91223

Q34150097-A6E732D5-48A3-48F4-AF3F-83303AFE2265

Q34150097-B7B0BCA9-6CE2-4B33-B635-28500C01E209

Q34150097-C0956B1D-E8E3-4331-B221-1650C4DF88D0

Q34150097-D29EDC19-2B81-418B-B494-87B66439AC0A

Q34150097-E5458F0C-9517-4AFF-AB36-E04E376BE656

Q34150097-EC0F064B-6DC0-498C-BF99-874F93F77564

P2860

Q34150097-039C5439-D04B-4105-B1C0-9E4B2EAA8387

Q34150097-06EED21D-A414-4E47-A4CC-CE05F7706A50

Q34150097-09FDD9E0-5B12-40F3-A20F-0E7869C74C00

Q34150097-0A6B6823-8857-4197-BF4A-CF7E14341CEC

Q34150097-15948F56-EC4A-4204-B04A-1D8B54FC4944

Q34150097-15F208DB-AB38-45F9-9BEC-74E51526DCA3

Q34150097-162CF038-CCF1-4F08-BF9F-96FA165110AA

Q34150097-1769D350-3D73-4E2F-B4A1-794D6987BD61

Q34150097-1BC286C7-2BFB-495C-9D94-CF2337F777FC

Q34150097-1BD00D1C-B0EA-4950-9D43-55F0D71DD9A5

P304

Q34150097-11FBA9AF-9CEE-4647-AD29-F7013487AE85

P31

Q34150097-4FD47DAD-5140-47C5-AF6A-4EFDABA96D32

P356

Q34150097-89FD5E21-C516-4A9F-9CBB-15647C20EF28

P433

Q34150097-04004FC9-615F-46D4-9600-03713BBC1131

P478

Q34150097-62AAD68B-4087-4E22-B20C-8C9F6CDAEF61

P577

Q34150097-6CF5E52D-D54B-47D1-9358-E2B367E402BE

P5875

Q34150097-E26EC816-284E-4BF6-9DDD-66DD3E48D527

P698

Q34150097-6DCD03D2-41C0-465D-B0F8-18CF793BA2E7

P921

Q34150097-C1B289B7-6ED3-4395-9DC8-5DCFB882FF7E

Q34150097-E5046259-7A10-4672-BAB4-8175E028D1D0

P356

P1433

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

P1476

Ovarian cancer biomarkers for molecular biosensors and translational medicine.

@en

P2093

Andre Goy

http://www.w3.org/2001/XMLSchema#string

Angelica Castro

http://www.w3.org/2001/XMLSchema#string

Hiren Patel

http://www.w3.org/2001/XMLSchema#string

K Stephen Suh

http://www.w3.org/2001/XMLSchema#string

Michael Liang

http://www.w3.org/2001/XMLSchema#string

Patrick Blake

http://www.w3.org/2001/XMLSchema#string

Sang W Park

http://www.w3.org/2001/XMLSchema#string

P2860

The detection, treatment, and biology of epithelial ovarian cancer

YKL-40 tissue expression and plasma levels in patients with ovarian cancer

Ovarian carcinoma subtypes are different diseases: implications for biomarker studies

Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker

Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts

Cancer statistics, 2008

Favorable prognostic value of tissue human kallikrein 11 (hK11) in patients with ovarian carcinoma

Characterization of the oligosaccharides associated with the human ovarian tumor marker CA125

Role of nerve growth factor and FSH receptor in epithelial ovarian cancer

SMRP and HE4 as biomarkers for ovarian carcinoma when used alone and in combination with CA125 and/or each other

P304

1069-1083

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERM.10.87

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2010-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47808481

http://www.w3.org/2001/XMLSchema#string

P698

21080822

http://www.w3.org/2001/XMLSchema#string

P921